Jim Simons Bio Xcel Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 129,869 shares of BTAI stock, worth $76,622. This represents 0.0% of its overall portfolio holdings.

Number of Shares

129,869

Holding current value

$76,622

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.53 - $1.34 $68,830 - $174,024	129,869 New	129,869 $79,000
Q1 2024 May 13, 2024	BUY	$1.95 - $4.04 $46,228 - $95,776	23,707 New	23,707 $67,000
Q1 2023 May 12, 2023	BUY	$17.7 - $33.24 $1.66 Million - $3.12 Million	94,000 New	94,000 $1.75 Million
Q3 2022 Nov 14, 2022	SELL	$11.19 - $17.89 $224,919 - $359,589	-20,100 Reduced 36.15%	35,500 $420,000
Q2 2022 Aug 12, 2022	BUY	$9.03 - $21.55 $332,304 - $793,040	36,800 Added 195.74%	55,600 $734,000
Q1 2022 May 13, 2022	BUY	$15.0 - $22.83 $282,000 - $429,203	18,800 New	18,800 $393,000
Q3 2020 Nov 13, 2020	SELL	$37.44 - $64.63 $5.83 Million - $10.1 Million	-155,600 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$17.62 - $58.71 $1.46 Million - $4.88 Million	83,100 Added 114.62%	155,600 $8.25 Million
Q1 2020 May 14, 2020	SELL	$12.26 - $41.14 $29,424 - $98,736	-2,400 Reduced 3.2%	72,500 $1.62 Million
Q4 2019 Feb 13, 2020	SELL	$4.05 - $14.61 $11,340 - $40,908	-2,800 Reduced 3.6%	74,900 $1.09 Million
Q3 2019 Nov 13, 2019	BUY	$7.04 - $11.77 $42,944 - $71,797	6,100 Added 8.52%	77,700 $547,000
Q2 2019 Aug 12, 2019	BUY	$8.99 - $11.79 $240,932 - $315,972	26,800 Added 59.82%	71,600 $785,000
Q1 2019 May 14, 2019	BUY	$3.49 - $10.47 $156,352 - $469,056	44,800 New	44,800 $443,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.14M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $16.5M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account